Interlace Medical Inc., a Framingham, Mass.-based developer of medical devices for the in-office polypectomy/myomectomy market, has raised $20.5 million in Series C funding. Baird Venture Partners and HLM Venture Partners co-led the round, and were joined by Hambrecht & Quist Capital Management, Aperture Venture Partners and return backers New Leaf Venture Partners and Spray Venture Partners.
